Annual report pursuant to Section 13 and 15(d)

Collaboration and Research Arrangements - Other Research Agreements (Details)

v3.19.3.a.u2
Collaboration and Research Arrangements - Other Research Agreements (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue From Contract With Customer [Line Items]        
Revenue recognized   $ 2,000,000 $ 2,100,000  
Contract liabilities, additions   20,158,000    
Multinational Pharmaceutical Company | Other Research Agreements        
Revenue From Contract With Customer [Line Items]        
Revenue recognized       $ 1,100,000
GBT [Member]        
Revenue From Contract With Customer [Line Items]        
Contract liabilities, additions   20,000,000    
GBT [Member] | Collaboration Agreement        
Revenue From Contract With Customer [Line Items]        
Revenue recognized   0    
Contract liabilities, additions $ 20,000,000      
Incyte        
Revenue From Contract With Customer [Line Items]        
Revenue recognized   2,000,000 $ 2,100,000  
Contract liabilities, additions   $ 158,000    
Incyte | Collaboration Agreement        
Revenue From Contract With Customer [Line Items]        
Upfront payment due 20,000,000      
Deferred revenue incurred 200,000      
Amount offset by revenue recognition $ 2,000,000